Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc7693dae06e6b3ff39c820ec91bf5db |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2020-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d039f396586d95d095c0419aabf5967 |
publicationDate |
2021-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021106664-A1 |
titleOfInvention |
Alpha-lactalbumin vaccination for inhibiting growth and development of male breast cancers |
abstract |
Methods comprising a step of administering, to a mammalian male subject, a composition comprising α-lactalbumin for the treatment of male breast cancer. |
priorityDate |
2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |